Why is the 4DMedical share price exploding 40% today?

4DMedical signed a three-year, nationwide contract with I-MED Radiology Network.

| More on:
Man pointing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • 4DMedical share price rockets 40% 
  • The company announced a three-year contract with I-MED 
  • 4DMedical can now send its lung imaging technology to selected clinics among I-MED’s 250 clinic network 

The 4DMedical Ltd (ASX: 4DX) share price is surging today, up 39.6% after posting gains of as much as 95% in early morning trade.

4DMedical shares closed yesterday at 36 cents and are currently trading for 51 cents.

So what’s driving ASX investor interest in the respiratory imaging technology company?

Nationwide contract inked

The 4DMedical share price is rocketing after the company reported it has signed a nationwide contract with I-MED Radiology Network. I-MED has more than 250 clinics across Australia.

The new three-year agreement formalises an existing commercial arrangement between the two companies. 4DMedical is now cleared to send its lung imaging technology to other selected clinics across I-MED’s network.

Atop the agreement, the company said its agreed to establish a Lung Centre of Excellence together with I-MED. Employing its ling imaging technology, 4DMedical said the centre will “enable world-class research and development activities to advance diagnostic imaging throughout Australia”.

The 4DMedical share price could also be getting a lift from the company’s report that the collaboration with I-MED could streamline the adoption processes of its diagnostic imaging technology without requiring extensive pilot programs.

Commenting on the development

4DMedical CEO, Andreas Fouras said:

Expansion of our proven capability nationwide means many more people will be able to access the latest technology in respiratory imaging. Beyond putting our innovative technology in the reach of more people, this deal represents a significant opportunity to drive revenue for the company. Additionally, this agreement creates a framework for the rapid commercialisation of future 4DMedical products.

I-MED CEO Shrey Viranna added, “Activating this arrangement augments I-MED’s world-class diagnostic imaging offering through access to 4DMedical’s unique functional lung imaging technology.”

4DMedical share price snapshot

Despite today’s big lift, the 4DMedical share price remains down 59% in 2022. By comparison, the All Ordinaries Index (ASX: XAO) is down 13% year-to-date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Why this broker sees plenty of upside for the ResMed share price

ResMed shares could be in the buy zone...

Read more »

Two researchers discussing results of a study with each other.
Healthcare Shares

Looking to buy CSL shares? Here’s what to watch when the biotech company reports this week

Here’s what might be around the corner for CSL this earnings season.

Read more »

A scientist examining test results.
Healthcare Shares

Why did the Opthea share price dive 9% on Monday?

The biopharmaceutical company has announced new share issue arrangements.

Read more »

A disappointed female investor sits in front of her laptop and puts her hand to her forehead and closes her eyes in disappointment over share price falls
Capital Raising

Paradigm Biopharmaceuticals share price freefalls 27% following $66m cap raise

Paradigm shares have erased all of last week's gains...

Read more »

A woman stands facing a set of shelves that is completely empty.
Healthcare Shares

The ASX 200 company selling everything it makes due to its major competitor being out of the market: fundie

ResMed is performing strongly right now.

Read more »

a young woman props her hand under the face as she pokes her head out from under a luxurious doona in a bedroom decorated with flowers and a stylish lamp.
Healthcare Shares

Resmed share price dips despite profit and dividend boost

Profits and dividends are up, so why is the Resmed share price down?

Read more »

A sad looking scientist sitting and upset about a share price fall.
Earnings Results

Avita share price dives 16% on net loss

The medical technology company's shares are falling following today's financial results

Read more »

A man waking up happy with a smile on his face and arms outstretched representing the hefty Adairs dividend yield
Earnings Results

ResMed share price on watch following solid FY22 growth

ResMed has released its full year results...

Read more »